Pharmacodynamics in Simple Terms
Pharmacodynamics is the branch of pharmacology that explains what a drug does to the body. It tells us how a drug produces its effect, where it acts, what it interacts with, and why increasing the dose can increase the response.
When a drug enters the body, it does not act randomly. It interacts with specific biological targets such as receptors, enzymes, ion channels and transporters, or sometimes produces an effect through a simple physical or chemical action.
Understanding pharmacodynamics is therefore essential for understanding the mechanism of action of drugs.
Principles of Drug Action
Drugs generally do not create a completely new function in the body. Instead, they modify an existing physiological process. Depending on the drug and the tissue involved, this modification may increase activity, decrease activity, replace a deficient substance or selectively destroy unwanted cells.
1. Stimulation
Stimulation means increasing the activity of a particular cell, tissue or organ.
For example, adrenaline stimulates β₁-adrenoceptors in the heart and increases heart rate and force of contraction. Pilocarpine stimulates muscarinic receptors and increases salivary secretion. Caffeine increases CNS activity and promotes alertness.
However, excessive stimulation can become harmful. Therefore, the same pharmacological action that is useful at an appropriate dose may produce toxicity at a higher dose.
2. Depression
Depression is a reduction in the activity of a tissue or organ. CNS depressant drugs such as barbiturates reduce neuronal activity.
An important point is that a drug does not necessarily produce only stimulation or only depression throughout the body. Its effect depends on the receptor and tissue on which it acts.
For example, acetylcholine increases intestinal activity but decreases the rate of the SA node of the heart through different receptor mechanisms.
3. Replacement
Sometimes the body cannot produce enough of an essential substance. Administration of that substance can restore normal physiological function.
Examples include insulin in insulin deficiency, thyroxine in hypothyroidism, vitamin B₁₂ in deficiency and iron in iron-deficiency anaemia.
4. Cytotoxic Action
Some drugs act by damaging or killing unwanted cells or organisms. Antibacterial, antiparasitic and anticancer drugs are important examples.
The therapeutic aim is selective toxicity—to damage the target organism or abnormal cell more than the patient’s normal cells.
How Do Drugs Produce Their Effects?
Not every drug needs a receptor to produce its effect.
Some drugs act through simple physical or chemical mechanisms. For example, antacids neutralise gastric acid, ispaghula increases stool bulk, activated charcoal adsorbs certain poisons and mannitol produces an osmotic effect.
Many other drugs act on specific biological targets. The major targets are:
Enzymes, ion channels, transporters and receptors.
Enzymes
Drugs may inhibit enzymes and thereby alter important biochemical pathways.
For example, aspirin inhibits cyclooxygenase (COX) and reduces prostaglandin synthesis, contributing to its analgesic and anti-inflammatory effects.
Ion Channels
Ion channels control the movement of ions such as Na⁺, K⁺ and Ca²⁺ across cell membranes.
Lidocaine blocks sodium channels and prevents propagation of nerve impulses. Nifedipine blocks calcium channels and promotes vascular smooth-muscle relaxation.
Transporters
Transporters move substances across cell membranes. Blocking them can alter the concentration of important endogenous substances.
For example, fluoxetine inhibits the serotonin transporter and reduces serotonin reuptake, while furosemide inhibits the renal Na⁺-K⁺-2Cl⁻ cotransporter.
Receptors: The Communication System of the Cell
Receptors are mainly regulatory proteins that recognise chemical messengers and convert their binding into a biological response. They have a ligand-binding region and mechanisms that translate binding into cellular activity.
Think of a receptor as a message receiver. A hormone or neurotransmitter carries the message, the receptor receives it, and the receptor initiates changes inside the cell.
The important drug–receptor terms are:
Agonist
An agonist binds to a receptor and activates it.
Example: Morphine activates μ-opioid receptors and produces analgesia.
Antagonist
An antagonist binds to a receptor but does not activate it in the usual sense. Instead, it prevents an agonist from producing its effect.
Partial Agonist
A partial agonist activates the receptor but produces a submaximal response, even when receptor occupancy is high. This is because its efficacy is lower than that of a full agonist.
Inverse Agonist
Some receptors can show activity even when no agonist is present. This is called constitutive activity.
An inverse agonist reduces this basal activity by favouring the inactive receptor state.
Affinity and Efficacy
These two terms are extremely important in pharmacology.
Affinity describes the ability of a drug to bind to a receptor.
Efficacy describes the ability of the drug, once bound, to activate the receptor and produce a response.
Therefore, a drug can have high affinity but little or no efficacy. This is why an antagonist can bind strongly to a receptor while failing to activate it. Full agonists have sufficient efficacy to produce the maximum response, whereas partial agonists produce a lower maximum response.
Remember
Affinity = Binding
Efficacy = Activation/response
Theories of Drug–Receptor Action
Occupation Theory
The occupation theory relates drug effect to the occupation of receptors. As the concentration of a drug increases, more receptors become occupied and the response generally increases.
However, receptor occupancy and response are not always directly proportional. Some tissues contain more receptors than are necessary to produce a maximum response. These are often referred to as spare receptors.
This means that a full response may sometimes occur even when only a fraction of the total receptor population is occupied.
Two-State Receptor Model
The two-state model provides a simple explanation of how different ligands produce different effects.
A receptor is considered to exist in two states:
R = resting/inactive state
R = activated state*
An agonist has greater affinity for the activated state and shifts the receptor equilibrium towards R*. A neutral antagonist binds without significantly changing this equilibrium, thereby preventing other ligands from binding.
An inverse agonist preferentially binds the resting state and shifts the equilibrium towards R. This explains how inverse agonists can reduce constitutive receptor activity.
Classification of Receptors
The major receptor families are:
- G-protein-coupled receptors (GPCRs)
- Ligand-gated ion channels
- Kinase-linked receptors
- Receptors regulating gene expression
Each type uses a different mechanism to convert drug binding into a cellular response.
G-Protein-Coupled Receptors
GPCRs are characterised by seven transmembrane segments. When a ligand binds, the receptor activates a G-protein, which then regulates an enzyme or ion channel.
Three pathways are particularly important for examinations:
Gs → adenylyl cyclase ↑ → cAMP ↑
Gi → adenylyl cyclase ↓ → cAMP ↓
Gq → phospholipase C → IP₃ + DAG
IP₃ increases intracellular Ca²⁺, while DAG activates protein kinase C. These second messengers can then influence processes such as contraction, secretion and enzyme activity.
Easy Memory Trick
Gs = cAMP goes up
Gi = cAMP goes down
Gq = PLC → IP₃ + DAG
Ligand-Gated Ion Channels
These receptors directly control ion movement through a membrane channel. When the appropriate ligand binds, the channel opens or closes and ions rapidly move across the membrane.
Because there is little need for a long intracellular signalling cascade, these receptors produce some of the fastest receptor-mediated responses.
Examples include the nicotinic acetylcholine receptor and GABA-A receptor.
Kinase-Linked and JAK–STAT Receptors
Kinase-linked receptors have an extracellular ligand-binding region, a single transmembrane segment and an intracellular signalling region.
Many receptor tyrosine kinases respond to growth factors. Ligand binding promotes receptor dimerisation and phosphorylation, which activates intracellular signalling cascades such as the Ras/Raf/MAP kinase pathway involved in growth and differentiation.
JAK–STAT receptors are different because they lack intrinsic kinase activity. They use an associated cytoplasmic enzyme called Janus kinase (JAK).
The sequence is:
Ligand → receptor dimerisation → JAK activation → STAT phosphorylation → STAT dimerisation → nucleus → gene transcription
Cytokines, interferons, growth hormone and prolactin use this type of signalling.
Receptors Regulating Gene Expression
These receptors are located inside the cell and generally respond to lipid-soluble substances that can cross the cell membrane.
Examples include receptors for glucocorticoids, mineralocorticoids, sex hormones, thyroid hormones, vitamin D and retinoids.
After ligand binding, the receptor interacts with DNA and changes gene transcription. Because new proteins often need to be synthesised, these responses are generally slow in onset but prolonged in duration.
Regulation of Receptors
Receptors can change their sensitivity according to how much stimulation they receive.
Continuous or intense stimulation may produce desensitisation, in which the receptor becomes less responsive. GPCR desensitisation can involve receptor phosphorylation and internalisation.
Long-term stimulation can also reduce receptor number, known as down-regulation.
In contrast, prolonged deprivation or blockade of a receptor can produce up-regulation and supersensitivity. This helps explain why abrupt withdrawal of some drugs can produce exaggerated responses.
Dose–Response Relationship
The dose–response relationship describes how the magnitude of a drug’s effect changes as its concentration or dose increases.
Initially, increasing the concentration generally increases the response. Eventually, however, the response approaches a maximum because the available receptors or downstream mechanisms become limiting.
Two concepts are especially important:
Potency
Potency refers to how much drug is required to produce a particular effect.
A more potent drug produces the same specified effect at a lower concentration.
Efficacy
Efficacy refers to the maximum response that a drug can produce.
Therefore:
Potency = How much drug is needed?
Efficacy = How much effect can it produce?
These concepts should not be confused. A drug can be more potent without being more efficacious.
EC₅₀
EC₅₀ is the concentration of a drug required to produce 50% of its maximum effect.
A lower EC₅₀ generally indicates greater potency.
Quick Revision
| Concept | Key Point |
|---|---|
| Pharmacodynamics | What the drug does to the body |
| Affinity | Ability to bind |
| Efficacy | Ability to produce response |
| Agonist | Activates receptor |
| Antagonist | Blocks receptor activation |
| Partial agonist | Produces submaximal response |
| Inverse agonist | Reduces constitutive activity |
| GPCR | 7 transmembrane segments |
| Gs | ↑ cAMP |
| Gi | ↓ cAMP |
| Gq | PLC → IP₃ + DAG |
| JAK–STAT | Uses cytoplasmic JAK |
| Nuclear receptor | Regulates gene transcription |
| Potency | Amount required for an effect |
| Efficacy | Maximum effect |
| EC₅₀ | Concentration producing 50% maximum response |
Conclusion
Pharmacodynamics helps us understand how drugs produce their effects rather than simply memorising their actions. Drugs can act on enzymes, ion channels, transporters or receptors, and each target can produce its effect through a different mechanism.
Receptor pharmacology is particularly important because receptors convert chemical signals into cellular responses. GPCRs use G-proteins and second messengers, ion-channel receptors directly regulate ion movement, kinase-linked receptors activate phosphorylation pathways, JAK–STAT receptors regulate signalling through cytoplasmic kinases, and intracellular receptors influence gene transcription.
Finally, understanding affinity, efficacy, potency, EC₅₀, receptor regulation and dose–response relationships provides the foundation for understanding the mechanism and clinical effects of individual drugs.
References
- Rang H. P., Dale M. M., Ritter J. M., Flower R. J. Rang & Dale’s Pharmacology. Elsevier.
- Tripathi K. D. Essentials of Medical Pharmacology. Jaypee Brothers Medical Publishers.
- Sharma H. L., Sharma K. K. Principles of Pharmacology. Paras Medical Publisher.